This research was completed To judge the possible from the CPPs with tumor-targeting Houses to deliver a cytotoxic payload to HCC cells. We explored employing a CXCR4-focusing on peptide, T22, fused with cytotoxic peptide PE24, being a novel therapeutic approach for CXCR4+ HCC cells. T22 was chosen because the nanocarrier https://https1433147com39482.fare-blog.com/31556304/the-definitive-guide-to-https-1433778-com